# Internal Review - Round 1

**Reviewer:** Claude Code (Reviewer 2 mode)
**Paper:** Does Visibility Delay Frontier AI? Evidence from arXiv's Daily Cutoff
**Date:** 2026-03-03

---

## PART 1: CRITICAL REVIEW

### 1. Identification and Empirical Design

**Strengths:**
- The 14:00 ET cutoff is a clean, sharp discontinuity with a strong institutional basis.
- The first stage is large (~70pp shift in position percentile) and highly significant.
- The McCrary test, covariate balance, and placebo cutoffs all support validity.
- The donut RDD specifications address strategic timing concerns.

**Concerns:**
- The treatment bundles two effects: improved listing position AND a one-day delay in announcement. The paper acknowledges this but the reduced form cannot separate them. The survival analysis (Cox model) partially addresses timing, but the estimates are imprecise.
- Effective sample within the MSE-optimal bandwidth is small (N=86), limiting power. The MDE analysis is transparent about this, but the paper should more prominently acknowledge that the null result may reflect insufficient power rather than a true zero effect.

### 2. Inference and Statistical Validity

- Standard errors are properly computed via rdrobust with robust bias-corrected inference.
- Randomization inference p-values complement asymptotic inference.
- Sample sizes are now consistent across tables (N=86 for MSE-optimal bandwidth).
- Bandwidth sensitivity shows stability from 50% to 200% of MSE-optimal.

### 3. Robustness and Alternative Explanations

- Comprehensive robustness: bandwidth sensitivity, donut RDD, randomization inference, polynomial/kernel sensitivity, placebo cutoffs, day-of-week splits, year-by-year estimates.
- All robustness checks produce null results, strengthening the interpretation.
- The paper could benefit from a power analysis showing what effect sizes are detectable given N=86.

### 4. Contribution and Literature Positioning

- Novel outcome: frontier lab adoption rather than generic citations. This is a meaningful contribution to the science of science literature.
- Good positioning relative to Feenberg & Price (2017), Haque et al. (2009, 2010).
- Missing: Could cite Card & DellaVigna (2020) on referee decision-making and attention, or Ellison (2002) on the slowdown of the economics publishing process, as related attention-friction papers.

### 5. Results Interpretation and Claim Calibration

- The paper is honest about the null result and discusses it thoughtfully.
- The discussion of mechanisms (announcement delay vs. visibility) is well-reasoned.
- Policy implications are appropriately modest given the null finding.

### 6. Actionable Revision Requests

**Must-fix:**
1. Add explicit MDE discussion in abstract/introduction — readers need to know upfront whether the null is informative.
2. Power analysis: What fraction of the baseline adoption rate could the design detect? If MDE > control mean, the null is uninformative.

**High-value improvements:**
3. Consider fuzzy RDD (using position percentile as endogenous variable) to recover the per-percentile-point LATE, which would be more interpretable.
4. Add discussion of how results compare to Feenberg & Price (2017) in magnitude, not just direction.

**Optional polish:**
5. The year-by-year analysis is underpowered (N=5-15 per year). Consider pooling into early (2012-2017) and late (2018-2024) periods for more informative splits.

### 7. Overall Assessment

**Key strengths:** Novel question (frontier lab adoption), clean institutional setting, honest null result, comprehensive robustness.

**Critical weaknesses:** Small effective sample (N=86), underpowered for detecting modest effects, treatment bundles position with delay.

**Publishability:** The paper is competently executed but the small effective sample limits what can be learned. A revision that more prominently discusses statistical power and the informativeness of the null would strengthen the contribution. The frontier lab adoption framing is novel enough to sustain interest even with null results, provided the power discussion is transparent.

---

## PART 2: CONSTRUCTIVE SUGGESTIONS

1. Frame the null as the key finding: "We find that a 70-percentage-point shift in listing position does not detectably affect frontier lab adoption within 18 months." This is informative if the MDE is reasonable.
2. Consider extending the sample by using a wider bandwidth or pooling categories more aggressively.
3. The survival analysis (Cox) is interesting but underpowered. A Kaplan-Meier plot would provide a visual complement even if formal tests lack power.

---

DECISION: MINOR REVISION
